Bristol-Myers Squibb Company
CXCR4 receptor antagonists

Abstract:

The invention generally relates to compounds of formula I which are antagonists of CXCR4. The invention includes pharmaceutically acceptable salts, compositions, methods of making the compounds of formula I, and methods of using the compounds of formula I for therapeutic indications. ##STR00001##